Jump to main content
Jump to site search

Issue 18, 2019
Previous Article Next Article

MATE-Seq: microfluidic antigen-TCR engagement sequencing

Author affiliations


Adaptive immunity is based on peptide antigen recognition. Our ability to harness the immune system for therapeutic gain relies on the discovery of the T cell receptor (TCR) genes that selectively target antigens from infections, mutated proteins, and foreign agents. Here we present a method that selectively labels peptide antigen-specific CD8+ T cells using magnetic nanoparticles functionalized with peptide–MHC tetramers, isolates these specific cells within an integrated microfluidic device, and directly amplifies the TCR genes for sequencing. Critically, the identity of the peptide recognized by the TCR is preserved, providing the link between peptide and gene. The platform requires inputs on the order of just 100 000 CD8+ T cells, can be multiplexed for simultaneous analysis of multiple peptides, and performs sorting and isolation on chip. We demonstrate 1000-fold sensitivity enhancement of detecting antigen-specific TCRs relative to bulk analysis and simultaneous capture of two virus antigen-specific TCRs from a population of T cells.

Graphical abstract: MATE-Seq: microfluidic antigen-TCR engagement sequencing

Back to tab navigation

Supplementary files

Publication details

The article was received on 06 Jun 2019, accepted on 05 Aug 2019 and first published on 08 Aug 2019

Article type: Paper
DOI: 10.1039/C9LC00538B
Lab Chip, 2019,19, 3011-3021

  •   Request permissions

    MATE-Seq: microfluidic antigen-TCR engagement sequencing

    A. H. C. Ng, S. Peng, A. M. Xu, W. J. Noh, K. Guo, M. T. Bethune, W. Chour, J. Choi, S. Yang, D. Baltimore and J. R. Heath, Lab Chip, 2019, 19, 3011
    DOI: 10.1039/C9LC00538B

Search articles by author